Double-blind, triple-crossover trial of low doses of oral physostigmine in inherited ataxias.
D000105:Acetyl Coenzyme A / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D001192:Arylsulfatases / Q000172:deficiency; D001259:Ataxia / Q000188:drug therapy*; D001284:Atrophy / Q000188:drug therapy; D002526:Cerebellar Diseases / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007223:Infant; D010830:Physostigmine / Q000008:administration & dosage*; D010919:Placebos; D013684:Telangiectasis / Q000188:drug therapy
D010919:Placebos; D000105:Acetyl Coenzyme A; D010830:Physostigmine; D001192:Arylsulfatases